Applying a Risk-benefit Analysis to Outcomes in Tuberculosis Clinical Trials.
Miyahara, Sachiko
Applying a Risk-benefit Analysis to Outcomes in Tuberculosis Clinical Trials. [electronic resource] - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 02 2020 - 698-703 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural
1537-6591
10.1093/cid/ciz784 doi
Antitubercular Agents--therapeutic use
Clinical Trials as Topic
Humans
Isoniazid
Risk Assessment
Tuberculosis--drug therapy
Applying a Risk-benefit Analysis to Outcomes in Tuberculosis Clinical Trials. [electronic resource] - Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 02 2020 - 698-703 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural
1537-6591
10.1093/cid/ciz784 doi
Antitubercular Agents--therapeutic use
Clinical Trials as Topic
Humans
Isoniazid
Risk Assessment
Tuberculosis--drug therapy